secwatch.observer — SEC 8-K summary
======================================

Issuer:     PepGen Inc. (PEPG)
CIK:        0001835597
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0000950170-24-071617
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PepGen promotes Michelle Mellion to CMO, Hayley Parker to SVP Global Regulatory Affairs
--------------------------------------------------------------------------------

- Michelle Mellion, M.D., promoted to Chief Medical Officer effective immediately.
- Hayley Parker, Ph.D., promoted to Senior Vice President, Global Regulatory Affairs effective immediately.
- Mellion joined PepGen as SVP Head of Clinical Development; previously held roles at Fulcrum Therapeutics.
- Parker joined PepGen as VP Regulatory Affairs; previously led regulatory strategy at Scholar Rock.
- CEO McArthur cites their leadership in driving clinical and regulatory strategies for rare muscle disorders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835597/000095017024071617/0000950170-24-071617-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835597/000095017024071617/pepg-20240611.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-071617

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer